Cancer Treatment Reviews
Volume 29, Issue 1 , Pages 65-67 , February 2003

Immediate thoracic radiotherapy may not improve symptom control over delayed radiotherapy in people with unresectable non-small cell lung cancer and minimal symptoms: Abstracted from: Falk S, Girling D, White R et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. British Medical Journal 2002; 325: 465–72.

References 

  1. Asamura H, Naruke T. Lung carcinoma. In:  Hermanek P,  Gospodarowicz MK,  Henson DE,  Hutter RVP,  Sobin LH editor. Prognostic Factors in Cancer. Berlin, Germany: Springer Verlag; 1995;p. 118–129
  2. Komaki R, Scott CB, Byhardt R, Emami B, Asbell SO, Russell AH, et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable NSCLC. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:263–267
  3. Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, et al. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:1475–1482
  4. Plataniotis GA, Theofanopoulou MA. Treatment of Inoperable Stage III & IV Non-Small Cell Lung Cancer (NSCLC). The “average” Radiotherapist’s Point of View. Onkologie. 2001;25:333–339
  5. Medical Research Council Lung Cancer Working Party. Inoperable non-small-cell lung cancer: a MRC randomized trial with two fractions or ten fractions. Br J Cancer 1991; 63: 265–270
  6. Medical Research Council Lung Cancer Working Party. A medical research council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer and poor performance status. Br J Cancer 1992; 65: 934–941
  7. Plataniotis GA, Kouvaris JR, Dardoufas C, Kouloulias V, Theofanopoulou MA, Vlahos L. A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC). Effective palliation and patients’ convenience. Lung Cancer. 2002;35:203–207
  8. Macbeth FR, Wheldon TE, Grilling DJ, et al.  Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for NSCLC. Clin. Oncol. 1996;8:176–181
  9. Plataniotis GA, Kouvaris JR, Dardoufas C, et al.  A short course of palliative radiotherapy for inoperable non-small cell lung cancer: Biologically effective dose on spinal cord. Clin. Oncol. 2000;12:335–337
  10. MacBeth . Radiation myelitis and thoracic radiotherapy: evidence and anecdote. Clin. Oncol. 2000;12:333–334
  11. MacBeth F. Radiotherapy for non-small-cell lung cancer: fractionation and cost-effectiveness. In:  Zatlowkeou P,  PetruŽelka L editor. Lung Cancer: Current Topics. Prague: Scientia Medica; 1996;p. 69–74
  12. Scaafsma J, Coy P. The effect of radiotherapy on the survival of non-small cell lung cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:291–298
  13. Macbeth FR, Bolger JJ, Hopwood P, et al.  Randomised trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable NSCLC and good performance status. Clin. Oncol. 1996;8:167–175
  14. Nguyen LN, Komaki R, Allen P, et al.  Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer and borderline prognostic factors without distant metastasis: a retrospective review. Int. J. Radiat. Oncol. Biol. Phys. 1999;44:1053–1056
  15. Baldini EH. Palliative radiation therapy for non-small cell lung cancer. Hematol. Oncol. Clin. North Am. 1997;11:303–319

☆ Sources of funding: Medical Research Council.

☆☆ For correspondence: R. J. Stephens, Department of Oncology, Bristol Oncology Centre, UK. E-mail: rs@ctu.mrc.ac.uk.

★ Abstract provided by Bazian Ltd, London.

PII: S0305-7372(02)00126-3

doi: 10.1016/S0305-7372(02)00126-3

Cancer Treatment Reviews
Volume 29, Issue 1 , Pages 65-67 , February 2003

Article Tools